Literature DB >> 10566715

Comparison of the color of fecal blood with the anatomical location of gastrointestinal bleeding lesions: potential misdiagnosis using only flexible sigmoidoscopy for bright red blood per rectum.

K D Fine1, A C Nelson, R T Ellington, A Mossburg.   

Abstract

OBJECTIVE: Flexible sigmoidoscopy has been recommended for diagnosis of patients with bright red rectal bleeding. The purpose of this study was to determine whether lesions associated with bright red hematochezia are located in the distal 60 cm of the colorectum and, therefore, in reach of a flexible sigmoidoscope.
METHODS: Three hundred-twelve consecutive patients presenting with hematochezia were shown a card containing three shades of red and asked to choose the color most representative of their fecal blood. Patients then underwent colonoscopy. The colonoscopist noted the length of the scope inserted when bleeding lesions were found.
RESULTS: Of 217 patients with bright red hematochezia, 181 bled from the distal 60 cm of the colon, 20 had more proximal lesions (including eight with cancer), and 16 had no lesion found. However, 140 patients with rectosigmoid neoplasms or nonbleeding nonneoplastic lesions (e.g., hemorrhoids, diverticula, vascular anomalies, and fissures) if found by sigmoidoscopy would have subsequently required full colonoscopic surveillance. It was calculated that the average per patient medical charges employing an initial colonoscopic approach would save $12 or $116 over one beginning with sigmoidoscopy (depending on whether sigmoidoscopy is performed in an office setting or endoscopy suite, respectively), and would reduce the probability of perforation slightly.
CONCLUSION: A diagnostic approach to hematochezia beginning with colonoscopy should be more effective, safer, and less costly than one beginning with flexible sigmoidoscopy, even when the blood is bright red.

Entities:  

Mesh:

Year:  1999        PMID: 10566715     DOI: 10.1111/j.1572-0241.1999.01519.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  8 in total

Review 1.  Management of colorectal cancers.

Authors:  R Lewis; A Flynn; M E Dean; A Melville; A Eastwood; A Booth
Journal:  Qual Saf Health Care       Date:  2004-10

2.  Canadian consensus on medically acceptable wait times for digestive health care.

Authors:  William G Paterson; William T Depew; Pierre Paré; Denis Petrunia; Connie Switzer; Sander J Veldhuyzen van Zanten; Sandra Daniels
Journal:  Can J Gastroenterol       Date:  2006-06       Impact factor: 3.522

3.  Colonoscopic evaluation of hematochezia in low and average risk patients for colorectal cancer: a prospective study.

Authors:  Puglisi Carlo; Russo-Francesco Paolo; Barbera Carmelo; Incarbone Salvatore; Aprile Giuseppe; Bonanno Giacomo; Russo Antonio
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

4.  Endoscopy for hematochezia in patients under 50 years of age.

Authors:  J D Lewis; C E Shih; D Blecker
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

5.  Effect of misdiagnosis on the prognosis of anorectal malignant melanoma.

Authors:  Sen Zhang; Feng Gao; Desen Wan
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-04       Impact factor: 4.553

Review 6.  Hematochezia in the young patient: a review of health-seeking behavior, physician attitudes, and controversies in management.

Authors:  Rashid Khan; David Hyman
Journal:  Dig Dis Sci       Date:  2009-02-24       Impact factor: 3.199

7.  Audit on flexible sigmoidoscopy for rectal bleeding in a district general hospital: are we over-loading the resources?

Authors:  J Mathew; P Shankar; I M Aldean
Journal:  Postgrad Med J       Date:  2004-01       Impact factor: 2.401

8.  Video capsule endoscopy as a tool for evaluation of obscure overt gastrointestinal bleeding in the intensive care unit.

Authors:  Shahrad Hakimian; Salmaan Jawaid; Yurima Guilarte-Walker; Jomol Mathew; David Cave
Journal:  Endosc Int Open       Date:  2018-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.